2008

INTERNATIONALE WETENSCHAPPELIJKE PUBLICATIES (peer reviewed):

• Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG on behalf of the LADIS Study Group. Association of gait and balance disorders with age-related white matter changes:  the LADIS study. Neurology 2008;70:935-942.
• Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten ECW, van der Flier WM, Hsu C, Wu S, Lane R. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin 2008;24:2561-2574.
• Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, Frost C, Scahill  RI, Fox NC. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage 2008;40:1655-1671.
• Barnes J, Scahill RI, Frost C, Schott JM, Rossor MN, Fox NC. Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging, Neurobiol Aging 2008;29:1199-1203.
• Bastos-Leite AJ, Kuijer JPA, Rombouts SARB, Sanz-Arigita E, van Straaten EC, Gouw AA, van der Flier WM, Scheltens P, Barkhof F. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296-1301.
• Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, King A, Scahill R, Warren JD, Fox NC, Rossor MN, Collinge J, Mead S. A distinct clinical, neuropsychological and radiological phenotype is associated  with progranulin gene mutations in a large UK series. Brain 2008;131:706-720.
• van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[ 11C]PK11195 positron emission tomography study. Biol Psychiatry 2008;64:820-822.
• Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DLG, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, Decarli C, Jack CR,  Fox NC, for the ADNI study. Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage 2008;39:1752-1762.
• Brenner D, Labreuche J, Pico F, Scheltens P, Poirier O, Cambien F, Amarenco P; on behalf of the GENIC Investigators. The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol 2008;255:993-1000.
• Camara O, Schnabel JA, Ridgway GR, Crum WR, Douiri A, Scahill RI, Hill DLG, Fox NC. Accuracy assessment of global and local atrophy measurement techniques  with realistic simulated longitudinal Alzheimer's disease images. Neuroimage 2008;42:696-709.
• Damoiseaux JS, Beckmann CF, Sanz Arigita EJ, Barkhof F, Scheltens Ph, Stam CJ, Smith SM, Rombouts SARB. Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex 2008;18:1856-1864.
• Dowling GA, Burr RL, van Someren EJW, Hubbard EM, Luxenberg JS, Mastick J, Cooper BA. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008;56:239-246.
• Drašković I, Vernooij-Dassen M, Verhey F, Scheltens P, Olde Rikkert M. Development of quality indicators for memory clinics. Int J Geriatr Psychiatry 2008;23:119-128.
• Dyrby TB, Rostrup E, Baaré WFC, van Straaten ECW, Barkhof F, Vrenken H, Ropele S, Schmidt R, Erkinjuntti T, Wahlund L-O, Pantoni L, Inzitari D, Paulson OB, Hansen LK, Waldemar G on behalf of  the LADIS study group. Segmentation of age-related white matter changes in a clinical multi-center study. Neuroimage 2008;41:335-345.
• Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 2008;32:412-419.
• van Eijsden P, Veldink JH, Linn FH, Scheltens P, Biessels GJ.  Progressive dementia and mesiotemporal atrophy on brain MRI: Neurosyphilis mimicking pre-senile Alzheimer's disease? Eur J Neurol 2008;15:e14-e15.
• Fassbender K, Lütjohann D, Dik MG, Bremmer M, König J, Walter S, Liu Y, Letièmbre M, von Bergmann K, Jonker C. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-The LASA study. Atherosclerosis, 2008;139:283-288..
• van der Flier WM, Scheltens P. Book review: Alzheimer’s disease: a broad overview. Lancet Neurol 2008;7:11.
• van der Flier WM, Pijnenburg YAL, Schoonenboom SNM, Dik MG, Blankenstein MA, Scheltens P. Distribution of APOE genotypes in a memory clinic cohort. Dement Geriatr Cogn Disord 2008;25:433-438.
• Frisoni GB, Henneman WJP, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund L-O, Zito G, Rossini PM, Winblad B, Barkhof F and the Alzheimer's Disease Neuroimaging Initiative. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement 2008;4:255-264.
• Frost C, Kenward MG, Fox NC. Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency? Stat Med 2008;27:3717-3731.
• Galluzzi S, Talassi E, Belussi M, Scheltens P, van de Pol L, Nobili F, Rodriguez G, Froelich L, Damian M, Martinez-Lage P, Gomez-Isla T, Reynish E, Ousset PJ, Vellas B, Frisoni GB. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease - data from the ICTUS study. Dement Geriatr Cogn Disord 2008;26:314-322 .
• Gauthier S, Dubois B, Feldman H, Scheltens Ph. Revised research diagnostic criteria for Alzheimer’sdisease. Lancet Neurol 2008;7:668-670.
• Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJG. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008;131:3286-3298.
• Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Fazekas F, Scheltens P, Barkhof F on behalf of the LADIS Study Group. On the etiology of incident brain lacunes. Longitudinal observations from the LADIS study. Stroke 2008;39:3083-3085.
• Gouw AA, van der Flier WM, Fazekas F, van Straaten ECW, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F, on behalf of the LADIS Study Group. Progression of white matter hyperintensities and incidence of new lacunes over a  3-year period. The Leukoaraiosis and Disability Study. Stroke 2008;39:1414-1420.
• Gouw AA, van der Flier WM, van Straaten ECW, Pantoni L, Bastos-Leite AJ, Inzitari D, Erkinjuntti T, Wahlund LO, Ryberg C, Schmidt R, Fazekas F, Scheltens P, Barkhof F.  Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 2008;25:247-253.
• Grundman M, Gilman S, Black RS, Fox NC, Koller M. An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease. Neurology 2008;71: 697.
• de Haan W, Stam CJ, Jones BF, Zuiderwijk IM, van Dijk BW, Scheltens P. Resting-state oscillatory brain dynamics in Alzheimer disease. J Clin Neurophysiol 2008;25:187-193.
• Henley SMD, Wild EJ, Hobbs NZ, Warren JD, Frost C, Scahill RI, Ridgway GR, MacManus DG, Barker RA, Fox NC, Tabrizi SJ. Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia 2008;46:2152-2160.
• Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR Jr, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta  L, Alexander GE, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008;41:19-34.
• Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DLG, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Colin Studholme C, DeCarli CS, Krueger G,  Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-691.
• Jacova C, Peters KR, Beattie BL, Wong E, Riddehough A, Foti D, Scheltens P, Li DK, Feldman HH. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup. Dement Geriatr Cogn Disord 2008;25:238-247.
• Jelles B, Scheltens Ph, van der Flier WM, Jonkman EJ, Lopes da Silva FH, Stam CJ. Global dynamical analysis of the EEG in Alzheimer's disease: frequency-specific changes of functional interactions. Clin Neurophysiol 2008;119:837-841.
• Joling KJ, van Hout HPJ, Scheltens P, Vernooij-Dassen M, van den Berg B, Bosmans J, Gillissen F, Mittelman M, van Marwijk HWJ. (Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial. BMC Geriatr 2008 Jan 21;8(2):1-9.
• Karas G, Sluimer J, Goekoop R, van der Flier W, Rombouts SARB, Vrenken H, Scheltens P, Fox N, Barkhof F. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944-949.
• Kerrsens CJ, Pijnenburg YAL. Vulnerability to neuroleptic side effects in frontotemporal dementia. Eur J Neurol 2008;15:111-112.
• Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack Jr CR, Ashburner J, Frackowiak RSJ. Automatic classification of MR scans in Alzheimer’s disease. Brain 2008;131:681-689.
• Klöppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RSJ. Accuracy of dementia diagnosis--a direct comparison between radiologists and a computerized method. Brain 2008;131:2969-2974.
• Klok RP, Klein PJ, van Berckel BNM, Tolboom N, Lammertsma AA, Windhorst AD. Synthesis of 2-(1,1-dicyanopropen-2-yl)-6-(2-[18F]-fluoroethyl)-methylamino-naphthalene ([18F]FDDNP). Appl Radiat Isot. 2008;66:203-207.
• Knight WD, Fox NC, Rossor MN, Warren JD. The cultural context of visual hallucinations. Postgrad Med J 2008;84:103-105.
• Koedam ELGE, Pijnenburg YAL, Deeg DJH, Baak MME, van der Vlies AE, Scheltens P, van der Flier WM.  Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord 2008;26:147-152.
• Kramer G, van der Flier WM, de Langen C, Blankenstein MA, Scheltens P, Stam CJ. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls. Clin Neurophysiol 2008;119:2727-2732.
• Lemstra AW, Kuiper RB, Schmand B, van Gool WA. Identification of responders to Rivastigmine: a prospective cohort study. Dement Geiatr Cogn Disord 2008;25:60-66.
• Lemstra AW, Kalisvaart KJ, Vreeswijk R, van Gool WA, Eikelenboom P. Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. Int J Geriatr Psychiatry 2008;23:943-948.
• Luurtsema G, Schuit RC, Takkenkamp K, Lubberink M, Hendrikse NH, Windhorst AD, Molthoff CFM, Tolboom N, van Berckel BNM, Lammertsma AA. Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites. Nucl Med Biol 2008;35:869-874.
• Mattsson N, Rüetschi U, Pijnenburg YAL, Blankenstein MA, Podust VN, Li S, Fagerberg I, Rosengren L, Blennow K, Zetterberg H. Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia. Mol Med Rep 2008;1:757-761.
• Miranda B, Madureira S, Verdelho A, Ferro J, Pantoni L, Salvadori E, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D on behalf of the LADIS Study. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes. J Neurol Neurosurg Psychiatry 2008;79:869-873.
• Moniz-Cook E, Vernooij-Dassen M, Woods R, Verhey F, Chattat R, De Vugt M, Mountain G, O'Connell M, Harrison J, Vasse E, Dröes RM, Interdem MO.
  A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health. 2008;12:14-29.
• Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Carioli A, Touchon J, Calvini P, Morbelli S, DeCarli F, Guerra UP, van de Pol LA, Visser PJ. Brain SPECT in subtypes of mild cognitive impairment; findings from the DESCRIPA  multicenter study. J Neurol 2008;255:1344-1353.
• Oosterman J, van Harten B, Vogels R, Gouw A, Weinstein H, Scheltens P, Scherder E. Distortions in rest-activity rhythm in aging relate to white matter hyperintensities. Neurobiol Aging 2008;29:1265-1271.
• Oosterman JM, Vogels RLC, van Harten B, Gouw AA, Scheltens Ph, Poggesi A, Weinstein HC, Scherder EJA. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning. Brain Cogn 2008;68:128-133.
• Oosterman JM, van Harten B, Weinstein HC, Scheltens P, Sergeant JA, Scherder EJ. White matter hyperintensities and working memory: an explorative study. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2008;15:384-399.
• Pijnenburg Y.A. Book review: Andrew Kertesz,The Banana Lady. Canada: Trafford  Publishing, 2006. Alzheimer Dis Assoc Disord 2008;22:113.
• Pijnenburg YAL, Mulder JL, van Swieten JC, Uitdehaag BMJ, Stevens M, Scheltens P, Jonker C. Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population. Dement Geiatr Cogn Disord 2008;25:157-164.
• Pijnenburg YAL, Strijers RLM, van de Made Y, van der Flier WM, Scheltens P, Stam CJ. Investigation of resting-state EEG functional connectivity in frontotemporal lobar degeneration. Clin Neurophysiol 2008;119:1732-1738.
• Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Verdelho A, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Crisby M, Waldemar G, Wallin A, Inzitari D, Pantoni L, on behalf of the LADIS Study Group. Urinary complaints in nondisabled elderly people with age-related white matter changes: The Leukoaraiosis And DISability (LADIS) Study. J Am Geriatr Soc 2008;56:1638-1643.
• Ramakers IHGB, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FRJ. The association between APOE genotype and memory dysfunction in subjects with mild cognitive iImpairment is related to age and Alzheimer pathology. Dement Geriatr Cogn Disord 2008;26:101-108.
• Ridgway GR, Omar R, Ourselin S, Hill DLG, Warren JD, Fox NC. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 2008;44:99-111.
• Ridgway GR, Henley SMD, Rohrer JD, Scahill RI, Warren JD, Fox NC.  Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008;40:1429-1435.
• Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC. Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. J Neurol 2008;255:567-574.
• van der Roest HG, Meiland FJM, Haaker T, Reitsma E, Wils H, Jonker C, Dröes RM.  Finding the service you need: Human centered design of a Digital Interactive Social Chart in DEMentia care (DEM-DISC). Stud Health Technol Inform 2008;137:210-224.
• van der Roest HG, Meiland FJ, Haaker T, Reitsma E, Wils H, Jonker C, Dröes RM. Finding the service you need: human centered design of a Digital Interactive Social Chart in DEMentia care (DEM-DISC). Stud Health Technol Inform 2008;137:210-224.
• van der Roest HG, Meiland FJM, van Hout HPJ, Jonker C, Dröes R-M. Validity and reliability of the Dutch version of the Camberwell Assessment of Need for the Elderly in community-dwelling people with dementia. Int Psychogeriatr 2008;20:1273-1290.
• Rohrer JD, Warren JD, Barnes J, Mead S, Beck J, Pepple T, Boyes R, Omar R, Collinge J, Stevens JM, Warrington EK, Rossor MN, Fox NC. Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol 2008;4:455-460.
• Rohrer JD, Warren JD, Omar R, Mead S, Beck J, Revesz T, Holton J, Stevens JM, Al-Sarraj S, Pickering-Brown SM, Hardy J, Fox  NC, Collinge J, Warrington EK, Rossor MN. Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 2008;65:506-513.
• Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, Warren JD. Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain 2008;131:8-38.
• Roks G, Korf ESC, van der Flier WM, Scheltens P, Stam CJ. The use of EEG in the diagnosis of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2008;79:377-380.
• Ryberg C, Rostrup E, Sjöstrand K, Paulson OB, Barkhof F, Scheltens P, van Straaten ECW, Fazekas F, Schmidt R, Erkinjuntti T, Wahlund L-O, Basile AM, Pantoni L, Inzitari D, Waldemar G, on behalf of the LADIS study group. White matter changes contribute to corpus callosum atrophy in the elderly: The LADIS Study. AJNR Am J Neuroradiol 2008;29:1498-1504.
• Sanders AH, Scheltens Ph. Book review: Thompson SBN, Dementia and memory: a handbook for students and professionals. Ashgate. Aldershot, Hampshire, 2006. Ageing & Society  2008;28:137-138.
• Schoonenboom NSM, van der Flier WM, Blankenstein MA, Bouwman FH, van Kamp GJ, Barkhof F, Scheltens P. CSF and MRI markers independently contribute to the diagnosis of Alzheimer’s disease. Neurobiol Aging 2008;29:669-675.
• Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC.  Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia 2008;46:1732-1737.
• Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM. Whole-brain atrophy rate in Alzheimer disease; Identifying fast progressors. Neurology 2008;70:1836-1841.
• Sluimer JD, van der Flier WM, Karas GB, Fox NC, Scheltens P, Barkhof F, Vrenken H. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
  Radiology 2008;248:590-598.
• Staekenborg SS, Gillissen F, Romkes R, Pijnenburg YAL, Barkhof F, Scheltens P, van der Flier WM. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer’s disease. Int J Geriatr Psychiatry  2008;23:387-392.
• Staekenborg SS, van der Flier WM, van Straaten ECW, Lane R, Barkhof F, Scheltens P.  Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke 2008;39:317-322.
• Staekenborg SS, van Straaten ECW, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia : risk factors and MRI findings. J Neurol 2008;255:1644-1651.
• van Straaten ECW, Harvey D, Scheltens Ph, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C; for the members of the Alzheimer’sDisease Cooperative Study Group. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 2008;255:1302-1308.
• van Swieten JC, Heutink P, Scheltens P. (Guest eds), Abstracts of the 6th International Conference on Frontotemporal Dementias September 3–5, 2008, Rotterdam, The Netherlands. Dement Geriatr Cogn Disord 2008;26 (suppl.1):94 pp.
• Tofts PS, Jackson JS, Tozer DJ, Cercignani M, Keir G, Macmanus DG, Ridgway GR, Ridha BH, Schmierer K, Siddique D, Thornton JS, Wroe SJ, Fox NC. Imaging cadavers: Cold FLAIR and noninvasive brain thermometry using CSF diffusion. Magn Reson Med 2008;59:190-195.
• Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G; for the European Task Force Group (waaronder Fox N.). Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurol 2008;7:436-450.
• Verwey N.A. Book review: G.L. Collingridge et al. (eds), Neurobiology of Alzheimer’s disease, 3rd edition. New York: Oxford University Press Inc. 2007. Alzheimer Dis Assoc Disord 2008;22:114-115.
• Verwey NA, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, Scheltens P, Blankenstein MA, Veerhuis R. Serum amyloid P component as a biomarker in mild cognitive impairment and Alzheimer’s disease. Dement Geriatr Cogn Disord 2008;26:522-527.
• Verwey NA, Bouwman FH, van der Flier WM, Veerhuis R, Scheltens P, Blankenstein MA. Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements. Clin Chem Lab Med 2008;46:1300-1304.
• Visser PJ, Verhey FRJ, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frölich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud A-S, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund L-O, Wilcock G, Winblad B, DESCRIPA study group. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology 2008;30:254-265.
• Visser PJ, Verhey FRJ. Mild cognitive impairment as predictor for Alzheimer’s disease in clinical practice: effect of age and diagnostic criteria. Psychol Med 2008;38:113-122.
• Vogels RLC, Oosterman JM, Laman DM, Gouw AA, Schroeder-Tanka JM, Scheltens P, van  der Flier WM, Weinstein HC. Transcranial Doppler blood flow assessment in patients with mild heart failure: correlates with neuroimaging and cognitive performance. Congest Heart Fail 2008;14:61-65.
• Wessels AM, Scheltens P, Barkhof F, Heine RJ. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 2008;585:88-96.
• Winblad B, Frisoni GB, Frolich L, Johannsen P, Johansson G, Kehoe P, Lovestone S, Olde-Rikkert M, Reynish E, Visser PJ, Vellas B. Editorial: EADC (European Alzheimer Disease Consortium) Recommendations for Future Alzheimer Disease Research in Europe. J Nutr Health Aging 2008;12:683-684.
• Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ,  Wang D, Brashear HR, Nye JS; the GAL-INT-11/18 Study Group (waaronder Scheltens P). Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 2008;70:2024-2035.
• Yaqub M, Tolboom N, Boellaard R, van Berckel BNM, van Tilburg EW, Luurtsema G, Scheltens P, Lammertsma AA. Simplified parametric methods for [11C]PIB studies. Neuroimage 2008;42:76-86.

Boekhoofdstukken, Nederlandstalige vakpublicaties

• van Berckel B, Tolboom N, Scheltens P.  PET imaging in dementia: future prospects. Nederlandse Studieclub voor Neurochirurgie, vrijdag 11 april 2008, VU medisch centrum Amsterdam.
• Binnewijzend MAA, Staekenborg SS, Eekhof JLA. Een patiënt met de ziekte van Alzheimer en enkele microbloedingen. Tschr Neurol Neurochir 2008;109:338-342.
• Griëntschnig CG, Scheltens P, van der Waal I. Een patiënt met een atypische pijnklacht in de onderkaak. Ned Tijdschr Tandheelkd 2008;115:41-43.
• Karas G, Scheltens P, Barkhof F. Feature extraction and strategy of analyzing structural neuroimaging in dementia. Handb Clin Neurol 2008;89:75-86.
• Lemstra A, van Gool P. Cholinesteraseremmers te breed ingezet. Pharm Weekbl 2008;143:34-38.
• Lemstra AW, Scheltens Ph. Dementie: stand van zaken. Medicamenteuze behandeling.  Modern Medicine 2008;32:112-115
• Lemstra AW, Scheltens Ph. Medicamenteuze behandeling bij de ziekte van Alzheimer. In: Biemond Cursus: Therapie in de neurologie, vrijdag 14 maart 2008 te Arnhem en vrijdag 12 december 2008 te Veldhoven. Utrecht, Nederlandse Vereniging voor Neurologie, 2008:52-57.
• Pijnenburg YAL. Commentaar: Het EEG in de differentiaaldiagnose van dementie. HealthDirect Neurologie 2007;4(2):18.
• Pijnenburg YAL. Commentaar: Rijden met dementie: waar ligt de grens? HealthDirect Neurologie 2007;4(2):17.
• Pijnenburg, YAL. Language functions. Luigi Amaducci teaching course on dementia: basic clinical knowledge. Teaching Course 5. 12th Congress of the European Federation of Neurological Societies Madrid, Spain, August 23-26, 2008.
• Romkes R. Dementie op jonge leeftijd: de lange weg van klachten naar diagnose en het traject daarna...... NeuroNieuws 2008;23:15-18.
• Sanders J, van Zonneveld D, Pijnenburg Y. De patiënt met gedragsverandering. In: Olde Rikkert MGM , Flamaing J, Petrovic M et al. (red), Probleemgeoriënteerd denken in de geriatrie.  Utrecht, De Tijdstroom, 2008:271-288.
• Scheltens P. Bewegen: goed voor het geheugen ? Ned Tijdschr Geneeskd, 2008;152:2583-2584.
• Scheltens Ph,  Frölich L.(Course directors), Luigi Amaducci teaching course on dementia: advanced insight in treatment options. Teaching Course 6. 12th Congress of the European Federation of Neurological Societies Madrid, Spain, August 23-26, 2008.
• Scheltens Ph, Dubois B (Course directors), Luigi Amaducci teaching course on dementia: basic clinical knowledge. Teaching Course 5.
  12th Congress of the European Federation of Neurological Societies Madrid, Spain, August 23-26, 2008.
• Scheltens Ph. Overview of current treatments: pros and cons & new amyloid lowering strategies: do they work clinically ?  Luigi Amaducci teaching course on dementia: advanced insight in treatment options. Teaching Course 6. 12th Congress of the European Federation of Neurological Societies Madrid, Spain, August 23-26, 2008.
• Stokman P, Klein M, Roos-Reuling I, Koene T, van der Vlies A, Scheltens P, van der Flier W. De diagnostische waarde van de Visuele Associatie Test (VAT) in een geheugenpoliklinieksetting. Neuropraxis 200812:3-8.
• van Straaten ECW. Proefschriftbespreking: MRI-correlaten van vasculaire cerebrale laesies en cognitieve achteruitgang. Tschr Neurol Neurochir 2008;109:185-187.

Dissertaties

• Bouwman FH. CSF biomarkers in dementia: longitudinal aspects and combination with MRI. 
  Enschede, Printpartners Ipskamp, 2008. 144 pp. Proefschrift Amsterdam V.U. 
  Promotoren: Ph Scheltens, MA Blankenstein, Copromotoren:WM van der Flier
• Damoiseaux J. The brain at ‘rest’. An exploration of intrinsic brain connectivity in healthy subjects and patients with Alzheimer’s  disease.
  Enschede, PrintPartners Ipskamp B.V. 2008. 160 pp. Proefschrift Amsterdam V.U. 
  Promotoren:Ph Scheltens, F Barkhof, Copromotoren: SARB Rombouts, CJ Stam
• Karas G. MRI patterns of cerebral atrophy in dementia.
  Enschede, Printpartners Ipskamp, 2008. 198 pp.Proefschrift Amsterdam V.U. 
  Promotoren:F Barkhof, Ph Scheltens, Copromotoren:SARB Rombouts
• Lemstra AW. Cholinergic deficiency and inflammation in cognitive dysfunction.
  Enschede, PrintPartners Ipskamp, 2008. 135 pp.Proefschrift Universiteit van Amsterdam. 
  Promotor:WA van Gool, Copromotor:P. Eikelenboom
• Vogels RLC. Cognitive impairment in heart failure.
  Enschede, Ipskamp Grafische Specialisten, 2008. 126 pp. Proefschrift Amsterdam V.U.
  Promotor:Ph Scheltens,  Copromotor: H.C. Weinstein